Quality of Life Research

, Volume 9, Supplement 1, pp 739–745 | Cite as

The McCoy Female Sexuality Questionnaire

  • Norma L. McCoy
Article

Abstract

The McCoy Female Sexuality Questionnaire (MFSQ) was developed from the questionnaire used in a longitudinal study of the menopausal transition and designed to measure aspects of female sexuality likely to be affected by changing sex hormone levels. The original questionnaire was revised to insure that questions were easy to understand and that labels for the Likert scales described a continuum. The revised MFSQ contains 19 questions, 18 items using 7-point Likert scales with labels at the center and endpoints and one item requesting a frequency of activity. Seven studies involving both clinical and convenience samples and two with double blind randomized controlled trials used 7, 9, 10 or 17 MFSQ items and demonstrated acceptable reliability, internal consistency, apparent face and content validity as well as considerable evidence of construct validity. Results showed selected MFSQ item ratings decreased as women progressed through the menopausal transition, varied positively with endogenous estradiol and androgen levels, were higher in postmenopausal women receiving hormone replacement therapy (HRT), and differentiated between different types of oral contraceptives and the presence or absence of ovaries. Convergent validity was demonstrated for change in 9-item MFSQ score with change in psychological general well-being (PGWB) score and the Women's Health Questionnaire (WHQ) sex life subscale.

McCoy Female Sexuality Questionnaire (MFSQ) Questionnaire Sexuality Women 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McCoy NL, Matyas JR. McCoy Female Sexuality Ques-tionnaire. In: Davis CM, Yarber WL, Bauserman R, Scheer G, Davis SL (eds), Handbook of Sexuality-Related Mea-sures, Thousand Oaks, CA: Sage, 1998; 249–251.Google Scholar
  2. 2.
    Nathorst-Böös J, Hammar M. Effect on sexual life – a comparison between tibolone and a continous estradiol-norethisterone acetate regimen. Maturitas 1997; 26: 15–20.PubMedCrossRefGoogle Scholar
  3. 3.
    McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985; 7: 203–210.PubMedCrossRefGoogle Scholar
  4. 4.
    McCoy NL. Estrogen levels in relation to self-reported symptoms and sexuality in perimenopausal women. [Sum-mary] In: Flint M, Kronenberg F, Utian W (eds), Multi-disciplinary Perspectives in Menopause. Ann NY AcadSci 1990; 592: 450–452.Google Scholar
  5. 5.
    McCoy NL, Cutler W, Davidson JM. Relationships among sexual behavior, hot flashes, and hormone levels in peri-menopausal women. Arch Sex Behav 1985; 14: 385–394.PubMedCrossRefGoogle Scholar
  6. 6.
    Cutler WB, Garcia CR, McCoy NL. Perimenopausal sex-uality. Arch Sex Behav 1987; 16: 225–234.PubMedCrossRefGoogle Scholar
  7. 7.
    McCoy NL, Matyas JR. Oral contraceptives and sexuality in university women. Arch Sex Behav 1996; 25(1): 73–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Beach FA. Sexual attractivity, proceptivity, and receptivity in female mammals. Horm Behav 1976; 7: 105–138.PubMedCrossRefGoogle Scholar
  9. 9.
    McCoy NL. Methodological problems in the study of sexuality and the menopause. Maturitas 1998; 29(1): 51–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Nathorst-Böös J, Wiklund I, Mattsson L, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in post-menopausal women. Acta Obstet Gynecol Scand 1993; 72: 656–660.PubMedGoogle Scholar
  11. 11.
    Limouzin-Lamothe M, Mairon N, Joyce CRB, Le Gal M. Quality of life after menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol 1994; 170: 618–624.PubMedGoogle Scholar
  12. 12.
    Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J (eds), Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, USA: Le Jacq, 1984: 170–183.Google Scholar
  13. 13.
    Hunter M, Battersby R, Whitehead M. Relationships be-tween psychological symptoms, somatic complaints and menopausal status. Maturitas 1986; 8: 217–228.PubMedCrossRefGoogle Scholar
  14. 14.
    Hunter M. Emotional well being, sexual behavior and hormone replacement therapy. Maturitas 1990; 12: 299–314.PubMedCrossRefGoogle Scholar
  15. 15.
    Wiklund I. Methods of assessing the impact of climacteric complaints on quality of life. Maturitas 1998; 29: 41–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Nathorst-Böös J, von Schoultz B, Carlström K. Elective ovarian removal and estrogen replacement therapy – effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993; 14: 283–293.PubMedGoogle Scholar
  17. 17.
    Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Androgen status and sexual life in perimenopausal women. Menopause 1997; 4(2): 95–100.Google Scholar
  18. 18.
    Dennerstein L, Dudley EC, Hopper J, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997; 26(2): 83–93.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Norma L. McCoy
    • 1
  1. 1.Department of PsychologySan Francisco State UniversitySan FranciscoUSA

Personalised recommendations